Refine by
Biopharmaceutical Industry Articles & Analysis
17 articles found
Introduction Good Manufacturing Practice (GMP) cell banks play a crucial role in the biopharmaceutical industry, serving as foundational repositories of cell lines used for the production of therapeutic biological products. ...
The quest for transformative cell and gene therapies has ignited a wave of innovation in biopharmaceuticals. As the industry races to unlock these treatments’ full potential, the intricacies of therapy development present unprecedented challenges. ...
Adeno-associated viruses (AAV) have emerged as safe and effective vectors for gene therapy and the advancement of biopharmaceutical research. Today, navigating the complex landscape of AAV manufacturing has become a focal point for professionals in the biopharma industry looking to exploit this technology in the development of breakthrough treatments. ...
In 2022, our team continued its explosive growth on the back of the many successes we’ve achieved in preformulation, formulation, target product profiles, and helping our clients advance their products into the clinic. We’ve done all these things and more – and our numbers reflect that. It was a fitting way to celebrate our 10th anniversary as one of the industry’s leading ...
The arrival of the COVID-19 pandemic has challenged the world’s health system and organization. To control and prevent this virus and others of its kind, vaccination has been adopted as an effective way to protect public health. Vaccines are chemical and biological products, which means they are sensitive to both cold and heat and must be kept in cold storage throughout the vast cold ...
Annalisa Jenkins' inspirational career spans over 25 years in the global biopharma industry – she started her career at St Barts, in London, where she trained as a cardiologist, before joining the British Royal Navy as a medical officer during the Gulf Conflict, achieving the rank of surgeon lieutenant commander during her time there. Annalisa spent almost two decades producing a pipeline ...
There is a growing need to address the high failure rate of drug candidates as they progress through clinical trials. Altis Biosystems aims to bring its technological advances to the forefront, enabling the drug development process to more effectively translate results from preclinical experiments to late-stage clinical trials. Breaking the Conformity of Inadequate Testing Platforms The ...
Biosortia is building the world’s largest library of microbiome-derived compounds for therapeutic and other applications, by leveraging the company’s microbial harvesting platform to sample and mine aquatic microbiomes at unprecedented scales with sustainable and environmentally friendly approaches. Biosortia is seeking partners interested in accessing compounds and chemistries to ...
Few sectors are as captive to water requirements and regulations as the biopharmaceutical industry. Water is a critical component in the manufacture of active pharmaceutical ingredients (APIs), life-saving drugs, vaccines, PPE, testing kits and many more products. ...
ABSTRACT Engineering controls designed to mitigate exposure and create separation between the operator and the toxic material are available in many different forms, all with their own unique advantages and risks. This article will look into various forms of containment while asking the question, is your liability assured or insured? ASSURANCE VS INSURANCE Assurance is defined as a positive ...
They are the preferred decision in the biopharmaceutical industry on the grounds that they are in a perfect fit world in circumstances where unhindered flow, strangulation and positive closure are required for ultra-pristine and delicate environments. ...
Sparta Systems decided to run its Stratas quality management platform on Amazon Web Services (AWS). “A lot of our customers in the biopharma and medical-device industries had already started to use Amazon for GxP and non-GxP workloads,” says Kratz. “That history is meaningful. We believe AWS is well ahead of its competitors when it comes to working with life sciences industry ...
A few things stood out in my mind as key indicators of where the biopharmaceutical industry is heading in this challenging area of analysis. ...
In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that ...
Thus, using the traditional stochastic frontier analysis to estimate the production technical efficiency of the biopharmaceutical industry may lead to erroneous conclusions. This paper has the advantage of being able to solve the possible bias that might arise from assuming that frontiers are identical as in conventional studies, and the inefficiencies can be ...
The commercial use of embryonic or adult stem cells is still in its infancy. Most young firms concentrated on the generation and storage of stem cells, the development of tissues and related equipment. But the perspectives of therapeutic use of stem cells attract a lot of political and commercial attention to possible new strategic markets opening up new fields besides incumbent ...
Animal experimentation has provoked debate since its establishment, in the modern sense. Recent years have seen a culmination of the debate. Animal rights campaigners have used direct action in order to stop experimentation, and both the industry and the government have replied through toughening security and implementing legislative changes. The main issue is ethics: can we, and on what grounds, ...